1 day Ago By Defense World Staff
Norges Bank acquired a new stake in shares of Fortrea Holdings Inc. ( NASDAQ:FTRE – Free Report ) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 17,685 shares of the company’s stock, valued at approximately $330,000.
Other institutional investors have also made changes to their positions in the company. Easterly Investment Partners LLC purchased a new stake in Fortrea during the 4th quarter worth $1,902,000. WINTON GROUP Ltd purchased a new stake in shares of Fortrea during the fourth quarter worth about $1,134,000.
Prudential Financial Inc. increased its position in shares of Fortrea by 13.0% during the fourth quarter.
Prudential Financial Inc. now owns 102,835 shares of the company’s stock worth $1,918,000 after acquiring an additional 11,859 shares during the last quarter. Vanguard Group Inc.
lifted its stake in shares of Fortrea by 1.2% in the fourth quarter. Vanguard Group Inc.
now owns 9,884,256 shares of the company’s stock worth $184,341,000 after acquiring an additional 120,599 shares in the last quarter. Finally, Fox Run Management L.L.
C. purchased a new position in Fortrea in the fourth quarter valued at about $302,000. Analyst Upgrades and Downgrades FTRE has been the topic of several analyst reports.
Mizuho dropped their price objective on Fortrea from $12.00 to $10.00 and set a “neutral” rating on the stock in a report on Wednesday.
William Blair restated a “market perform” rating on shares of Fortrea in a research note on Tuesday, March 4th. Evercore ISI reduced their price objective on shares of Fortrea from $20.00 to $15.
00 and set an “in-line” rating on the stock in a research note on Tuesday, March 4th. Robert W. Baird set a $12.
00 target price on shares of Fortrea in a research report on Tuesday, March 4th. Finally, Barclays restated an “underweight” rating and issued a $6.00 target price (down previously from $12.
00) on shares of Fortrea in a research note on Thursday. Two investment analysts have rated the stock with a sell rating and ten have given a hold rating to the stock. According to MarketBeat, Fortrea presently has a consensus rating of “Hold” and a consensus price target of $16.
70. Insiders Place Their Bets In other news, CEO Thomas Pike sold 11,268 shares of the business’s stock in a transaction on Monday, January 13th. The shares were sold at an average price of $18.
04, for a total transaction of $203,274.72. Following the completion of the transaction, the chief executive officer now owns 159,868 shares of the company’s stock, valued at approximately $2,884,018.
72. The trade was a 6.58 % decrease in their ownership of the stock.
The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website . Insiders have sold 13,029 shares of company stock valued at $226,168 over the last three months. Company insiders own 0.
12% of the company’s stock. Fortrea Price Performance Shares of NASDAQ:FTRE opened at $5.18 on Friday.
The company has a market cap of $467.24 million, a PE ratio of -1.51, a P/E/G ratio of 1.
78 and a beta of 2.10. Fortrea Holdings Inc.
has a fifty-two week low of $4.95 and a fifty-two week high of $39.49.
The firm has a 50-day simple moving average of $10.77 and a 200 day simple moving average of $16.20.
The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 0.
74. Fortrea ( NASDAQ:FTRE – Get Free Report ) last posted its earnings results on Monday, March 3rd. The company reported $0.
18 EPS for the quarter, missing the consensus estimate of $0.36 by ($0.18).
The company had revenue of $697.00 million for the quarter, compared to the consensus estimate of $703.22 million.
Fortrea had a negative net margin of 10.99% and a positive return on equity of 2.00%.
During the same period last year, the company posted $0.19 earnings per share. On average, sell-side analysts anticipate that Fortrea Holdings Inc.
will post 0.51 EPS for the current year. Fortrea Profile ( Free Report ) Fortrea Holdings Inc, a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide.
The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. Featured Articles Five stocks we like better than Fortrea Top Biotech Stocks: Exploring Innovation Opportunities Robinhood Strategies Could Be a Game-Changer for Young Investors Special Purpose Acquisition Company (SPAC) What You Need to Know Are These 3 Retail Stocks Oversold or Really in Trouble? Mastering Discipline: Overcoming Emotional Challenges In Trading IONQ & RGTI Join DARPA Quantum Initiative: High Stakes Are Ahead Want to see what other hedge funds are holding FTRE? Visit HoldingsChannel.
com to get the latest 13F filings and insider trades for Fortrea Holdings Inc. ( NASDAQ:FTRE – Free Report ). Receive News & Ratings for Fortrea Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fortrea and related companies with MarketBeat.
com's FREE daily email newsletter ..
